,i  #aae? ,,congress  #a/ ,session  ,h4 
,r4 #daij  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,octob] #ca1 #bjag,ms4
 ,ku/] ( ,new ,hamp%ire 7= h]self & ,mr4
 ,j5k9s ( ,we/ ,virg9ia7 introduc$ !    
foll[+ bill2 :i* 0 ref]r$ to !          
,committee on ,en]gy & ,comm]ce  ,a     
,,bill  ,to am5d ! #ba/ ,c5tury ,cures  
,act to ensure ! equitable di/ribution (
 res\rces to address ! opioid epidemic1 
& = o!r purposes4  #a4 ,%ort title ,?is 
,act may be cit$ z ! ,f$]al ,opioid     
,response ,fairness ,act ( #bjag4  #b4  
,equitable di/ribution ( res\rces to    
address ! opioid epidemic  7a7 ,9 g5]al 
,! second s5t5ce 9 p>agraph 7#a7 (      
section #ajjc7;c7 ( ! #ba/ ,c5tury      
,cures ,act 7,public ,law #aad-bee2 #db 
,u4,s4,c4 #bij;ee-#c note7 is am5d$ by  
/rik+ ,/ates ) an incid5ce or preval5ce 
( opioid use disord]s t is sub/antially 
high] relative to o!r ,/ates4 & ins]t+  
,/ates--  7,a7 ) an incid5ce or         
preval5ce ( opioid use disord]s &       
associat$ adv]se heal? effects1 includ+ 

neonatal ab/95ce syndrome1 t are        
sub/antially high] relative to o!r      
,/ates2  7,b7 9 :i* ! incid5ce rate (   
opioid use disord]s1 or ! opioid-relat$ 
drug ov]dose mortality rate1 is         
sub/antially high] ?an :at su* rate 0   
dur+ ! ye> imm$iately prec$+ ! ye> 9 :i*
 su* grants are aw>d$2 &  7,c7 ) a p]   
capita prescription opioid1 h]o91 or    
syn!tic opioid ov]dose mortality rate t 
is sub/antially high] relative to o!r   
,/ates4  4  7b7 ,te*nical am5dm5t ,!    
fir/ s5t5ce 9 p>agraph 7#a7 ( section   
#ajjc7;c7 ( ! #ba/ ,c5tury ,cures ,act  
7,public ,law #aad-bee2 #db ,u4,s4,c4   
#bij;ee-#c note7 is am5d$ by /rik+ 9    
accordance ) subp>agraph 7,b7 & ins]t+ 9
 accordance ) p>agraph 7#b74